Cargando…

Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML

Detalles Bibliográficos
Autores principales:	Petersen, Christopher, Li, Jian-Ming, Waller, Edmund
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649410/ http://dx.doi.org/10.1186/2051-1426-3-S2-P238

Ejemplares similares

VIPhyb, an Antagonist of Vasoactive Intestinal Peptide Receptor, Enhances Cellular Antiviral Immunity in Murine Cytomegalovirus Infected Mice
por: Li, Jian-Ming, et al.
Publicado: (2013)

Vasoactive intestinal peptide inhibits the production of Salmonella-induced inflammatory cytokines by human monocytes
por: Askar, B, et al.
Publicado: (2014)

Gene Expression Analysis Links Autocrine Vasoactive Intestinal Peptide and ZEB1 in Gastrointestinal Cancers
por: Rao, Ishani H., et al.
Publicado: (2023)

Significance of gain and loss of chromosomal abnormalities in AML: an Indian experience
por: Trivedi, Pina J, et al.
Publicado: (2014)

Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016)

Comparison of vasoactive medications and investigation determinants of mortality in children
por: Demirkol, D, et al.
Publicado: (2008)

CD8α+ dendritic cells dictate immune responses against murine AML
por: Kline, Douglas E, et al.
Publicado: (2013)

Total inotrope exposure score: an extension of the vasoactive inotrope score
por: Bangalore, H, et al.
Publicado: (2015)

Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)

Synergistic and antagonistic AML cell type-specific responses to 5-AZA-2’-Deoxycytidine and 1-H-D-Arabinofuranosylcytosine
por: Elmoneim, Abeer Abd, et al.
Publicado: (2014)

Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries –relevant to migraine?
por: Kruuse, Christina, et al.
Publicado: (2011)

Biologically-active exosomes in plasma of AML patients inhibit innate immunity and promote leukemia progression
por: Boyiadzis, Michael, et al.
Publicado: (2015)

A Phase I trial of MGD006 in patients with relapsed acute myeloid leukemia (AML)
por: Uy, Geoffrey, et al.
Publicado: (2014)

Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis
por: Hermel, Melody, et al.
Publicado: (2021)

Vasodilatory Effect of the Stable Vasoactive Intestinal Peptide Analog RO 25-1553 in Murine and Rat Lungs
por: Yin, Jun, et al.
Publicado: (2013)

What effect of vasoactive drugs on passive leg raising response in critically ill patients?
por: Alaya, S, et al.
Publicado: (2005)

P448: PROGNOSTIC SIGNIFICANCE OF MEASURABLE RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN AUTOLOGOUS STEM CELL APHERESIS PRODUCTS OF PATIENTS WITH AML
por: Tettero, Jesse, et al.
Publicado: (2023)

Effect of vasoactive drugs on the response of the baroreceptor and regulation of heart rate variability in patients with septic shock
por: Nogueira, AC, et al.
Publicado: (2013)

Select cognitive deficits in Vasoactive Intestinal Peptide deficient mice
por: Chaudhury, Dipesh, et al.
Publicado: (2008)

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide
Publicado: (1987)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation
por: Qu, Hongyi, et al.
Publicado: (2021)

Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor
por: Belei, Oana, et al.
Publicado: (2023)

P16-39. T cell recognition of autologous and non-autologous HIV-1 protease peptides by HIV-1 infected patients undergoing PI therapy
por: Moraes, SL, et al.
Publicado: (2009)

1110. Age-related effects of dexmedetomidine, an alpha-2 agonist, on coronary vasoactivity and cardiac function in guinea-pig hearts
por: Hongo, M, et al.
Publicado: (2014)

Vasoactive Intestinal Peptide and Its Receptors in Human Ovarian Cortical Follicles
por: Gabbay-Benziv, Rinat, et al.
Publicado: (2012)

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
por: Li, Bo, et al.
Publicado: (2019)

Vasoactive intestinal peptide regulates ileal goblet cell production in mice
por: Schwerdtfeger, Luke A., et al.
Publicado: (2020)

Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
por: Ataallah, Basma, et al.
Publicado: (2020)

Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension
por: Isaka, Mitsuhiro, et al.
Publicado: (2021)

Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid
por: Privalov, Evgeny, et al.
Publicado: (2023)

Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma
por: Ravindranathan, Sruthi, et al.
Publicado: (2022)

Adoptive immunotherapy for AML with CD123-engager T cells
por: Bonifant, Challice, et al.
Publicado: (2015)

Interleukin-1 receptor antagonist lentiviral gene transfer to the murine knee joint ameliorates collagen-induced arthritis
por: van de Loo, FAJ, et al.
Publicado: (2005)

P1686: LONG-TERM COMORBIDITY AND HEALTH PROBLEMS IN ACUTE MYELOID LEUKEMIA (AML) SURVIVORS: AN INTERNATIONAL AML SURVIVORSHIP STUDY
por: Efficace, Fabio, et al.
Publicado: (2023)

P55. Dendritic cell vaccination for postremission therapy in AML
por: Lichtenegger, FS, et al.
Publicado: (2014)

A269 THE MODULATION OF INTESTINAL INFLAMMATION BY PARABACTEROIDES GOLDSTEINII IN MURINE MODELS OF COLITIS
por: Gerkins, C, et al.
Publicado: (2023)

A271 THE MODULATION OF INTESTINAL INFLAMMATION BY PARABACTEROIDES GOLDSTEINII IN EXPERIMENTAL MURINE COLITIS
por: Gerkins, C, et al.
Publicado: (2023)

siRNAs targeting the ERK2 signaling pathway and AML1/MTG8 fusion gene attenuate the differentiation, proliferation and growth arrest in t(8;21) leukemia
por: Bashanfer, Salem, et al.
Publicado: (2012)

Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility
por: Nassif, A., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_0gfspqh4bj5kpshfj9t86fisul